Legal Wins, Stock Price Updates, Investors Conferences Participations - Research Report on Elan, ResMed, Cooper, PAREXEL, and

   Legal Wins, Stock Price Updates, Investors Conferences Participations -
        Research Report on Elan, ResMed, Cooper, PAREXEL, and Thoratec

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, December 2, 2013

NEW YORK, December 2, 2013 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Elan
Corporation, plc (NYSE: ELN), ResMed Inc. (NYSE: RMD), The Cooper Companies
Inc. (NYSE: COO), PAREXEL International Corporation (NYSE: PRXL) and Thoratec
Corp. (NASDAQ: THOR). Today's readers may access these reports free of charge
- including full price targets, industry analysis and analyst ratings - via
the links below.

Elan Corporation, plc Research Report

On November 27, 2013, Elan Corporation, plc's (Elan) stock decreased 0.28%,
ending the day's session at $18.08. Over the previous three trading sessions,
shares of Elan increased 0.22%, compared to the Dow Jones Industrial Average
Index, which increased 0.20% during the same period. The Full Research Report
on Elan Corporation, plc- including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/e996_ELN

--

ResMed Inc. Research Report

On November 20, 2013, ResMed Inc. (ResMed) announced that it has won
preliminary injunctions in Germany against several patent infringing
activities by APEX Medical Corp. (APEX) and BMC Medical Co., Ltd. (BMC).
According to the Company, the initial orders entered by the Munich District
Court, prohibits both APEX and BMC from selling or marketing of The APEX
WiZARD 210 and WiZARD 220 mask headgear; BMC's RESmart CPAP devices; and BMC's
Willow/FeaLite nasal pillows patient interface in Germany without a further
court order. "ResMed has a global business built on its investment in research
and development, resulting in products that excel in performance, quality and
comfort," said David Pendarvis, ResMed Global General Counsel and Chief
Administrative Officer. "We will continue to defend our investment in
intellectual property and pursue all legal remedies to prevent infringement in
any country where that infringement exists." The Full Research Report on
ResMed Inc.- including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/bd44_RMD

--

The Cooper Companies Inc. Research Report

On November 27, 2013, The Cooper Companies Inc.'s (Cooper) stock increased
0.88%, ending the day's session at $131.79. Over the previous three trading
sessions, shares of Cooper declined 1.36%, compared to the Dow Jones
Industrial Average Index, which increased 0.20% during the same period. The
Full Research Report on The Cooper Companies Inc.- including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.AnalystsCorner.com/r/full_research_report/9cde_COO

--

PAREXEL International Corporation Research Report

On November 27, 2013, PAREXEL International Corporation's (PAREXEL) stock
increased 0.15%, ending the day's session at $41.35. Over the previous three
trading sessions, shares of PAREXEL decreased 0.05%, compared to the Nasdaq
Composite Index, which increased 1.33% during the same period. The Full
Research Report on PAREXEL International Corporation- including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.AnalystsCorner.com/r/full_research_report/067b_PRXL

--

Thoratec Corp. Research Report 

On November 27, 2013, Thoratec Corp. (Thoratec) reported that the Company will
take part in two investor conferences in December 2013. The Company stated
that Taylor C. Harris, Vice President and CFO of Thoratec, is scheduled to
provide an update on the Company in the Piper Jaffray 25th Annual Health Care
Conference, on Wednesday, December 4, 2013, starting at 12:00 p.m., EST (9:00
a.m., PST). Additionally, the Company stated that Taylor will also speak at
the in the Oppenheimer 24th Annual Healthcare Conference on Tuesday, December
10, 2013, beginning at 2:10 p.m. EST (11:10 a.m., PST). Interested parties can
access a webcast of both presentations via the Company's website. The Full
Research Report on Thoratec Corp.- including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/1bee_THOR

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we
    are only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Namrata Maheshwari,
CFA, has only reviewed the information provided by Equity News Network in this
article or report according to the Procedures outlined by Equity News Network.
Equity News Network is not entitled to veto or interfere in the application of
such procedures by the outsourced provider to the articles, documents or
reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE Analysts' Corner

Contact: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North America)